|
Multiple Myeloma Treatment Information for Healthcare Professionals |
![[National Cancer Institute Logo]](../../images/ncilogo_nobar.gif) |
|
|
Diseases associated
with an M-protein included in this presentation are:
1. Asymptomatic plasma cell neoplasia with minimal evidence of disease aside
from the presence of an M-protein (monoclonal gammopathy of undetermined
significance, or MGUS).1
2. Symptomatic plasma cell neoplasia
a. primarily affecting bones
i. multiple myeloma 94%
ii. solitary plasmacytoma 3%
b. extramedullary plasmacytoma 3%
These usually occur in the nasopharynx, tonsils, or paranasal
sinuses.2
3. Macroglobulinemia. Patients often have lymphadenopathy and
hepatosplenomegaly; less than 5% have lytic bone lesions.
a. asymptomatic
b. symptomatic 3
References:
- Blade
J, Kyle RA: Monoclonal gammopathies of undetermined significance. In:
Malpas JS, Bergsagel DE, Kyle RA, et al. eds.: Myeloma: Biology and
Management. 2nd ed., Oxford, England: Oxford University Press, 1998, pp
513-544.
- Knowling
MA, Harwood AR, Bergsagel DE: Comparison of extramedullary plasmacytomas
with solitary and multiple plasma cell tumors of bone. Journal of
Clinical Oncology 1(4): 255-262, 1983.
- Kyle
RA, Garton JP: The spectrum of IgM monoclonal gammopathy in 430 cases.
Mayo Clinic Proceedings 62(8): 719-731, 1987.
Back
to Content Page
Next >>
|